Dramatic response to alectinib in a patient of ALK-rearranged lung cancer with poor performance status

BACKGROUND: Lung cancers with anaplastic lymphoma kinase rearrangements are highly sensitive to anaplastic lymphoma kinase tyrosine kinase inhibition, underscoring the notion that such cancers are addicted to anaplastic lymphoma kinase activity. Several anaplastic lymphoma kinase inhibitors have bee...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Res Notes
Main Authors: Tanaka, Hisashi, Taima, Kageaki, Morimoto, Takeshi, Nakamura, Kunihiko, Tanaka, Yoshihito, Itoga, Masamichi, Takanashi, Shingo, Okumura, Ken
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4794901/
https://ncbi.nlm.nih.gov/pubmed/26987388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-016-1983-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados